Prevention of mother-to-child transmisson of HTLV-1
Prevention of mother-to-child transmisson of HTLV-1
批准号:
04670607
负责人:
TSUJI Yoshiro
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994
中文摘要
预防HTLV-1的母婴传播。人类嗜t淋巴病毒I型(HTLV-1)与成人t细胞白血病(ATL)、热带痉挛性麻痹/HTLV-1相关脊髓病(TSP/HAM)和HTLV-1相关视网膜病(HAR)等严重疾病密切相关。不幸的是,目前还不可能治疗这些疾病。预防这些疾病的唯一可行方法是打破HTLV-1病毒的恶性循环。HTLV-1在长崎严重流行。长崎孕妇中带菌者的患病率约为4%。已确定HTLV-1的主要传播途径是母体,特别是通过母乳传播。孕产妇传播的发生率为20-30%。母体传播显著降低至配方奶喂养3%的水平。大约90%的产妇感染是通过不给带菌母亲喂奶而被阻断的。6月以上母乳喂养组感染发生率为16.2%,6月以下母乳喂养组感染发生率为10.4%,配方奶喂养组感染发生率为2.7%。比较长期母乳喂养组和短期母乳喂养组,我发现他们之间没有任何区别。
英文摘要
Prevention of mother-to-child transmission of HTLV-1.Human T-lymphotropic virus type I (HTLV-1) is closely linked with serious diseases, such as adult T-cell leukemia (ATL), tropical spastic pararesis/HTLV-1 associated myelopathy (TSP/HAM) and HTLV-1 assosiated retinophathy (HAR). Unfortunately, it is not currently possible to care the diseases. The only way aviable to provent thease diseases is breaking the cycle of HTLV-1 endemy.HTLV-1 is heavily endemic in Nagasaki. The prevelance of carriers in Nagasaki is approximately 4% in pregnant women.The main route of HTLV-1 transmission has been established as maternal, specifically via breast milk. The incidence of maternal transmission is 20-30%. Maternal transmission were remearkably decreased to the level of 3% in formula-fed.Approximately 90% of maternal infection was blocked by refraining of breast feeding by carrier mothers.The incidence of infection in group of breast-fed over 6 month was 16.2%, under 6 month was 10.4% and in the group of formula-fed was 2.7%.Comparing the long term breast-fed group and the short term-breast-fed group, I can't find any differene between them.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
辻 芳郎・松坂 哲応・島崎 幸治: "小児のHAM(HTLV-Iassociated myelopathy)" 帰床と研究. 69. 154-159 (1992)
Yoshiro Tsuji、Tetsuo Matsuzaka、Koji Shimazaki:“小儿 HAM(HTLV 相关性脊髓病)”恢复和研究 69. 154-159 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
土居 浩,辻 芳郎 他: "長崎県におけるHTLV-1母子感染予防の現状" 日本医事新報. 3676. 26-30 (1994)
Hiroshi Doi、Yoshiro Tsuji 等:“长崎县预防 HTLV-1 母婴传播的现状”日本医学报 3676. 26-30 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shigeru Katamine,Yoshiro Tsuji et al: "HTLV-1 provial DNA in umbilical cord blood of babies born to carrier mothers." Lancet. 343. 1326-1327 (1994)
Shigeru Katamine、Yoshiro Tsuji 等人:“携带者母亲所生婴儿脐带血中的 HTLV-1 原始 DNA。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shigeo Hino Yoshiro Tsuji et al: "Intervention of maternal transmission at HTLV-1 in Nagasaki Japan" Leukemia. 18. 68-70 (1994)
Shigeo Hino Yoshiro Tsuji 等人:“日本长崎 HTLV-1 母体传播的干预”白血病。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
辻 芳郎: "感染症の現況と対策:ウイルス感染症:HTLV-1感染" 日本医師会雑誌. 110. 264-267 (1993)
辻义郎:“传染病的现状和对策:病毒感染:HTLV-1感染”日本医学会杂志110. 264-267(1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Molecular-targeting chemotherapy related to p53-RB for malignant bone and soft tissue tumors
-
批准号:22591668
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:TSUJI Yoshiro
-
依托单位:
The role of eosinophil in allergic diseases.
-
批准号:02670449
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1990
-
负责人:TSUJI Yoshiro
-
依托单位:
Influence of myeloperoxidase to angitis in Kawasaki disease.
-
批准号:63570446
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.83万
-
财政年份:1988
-
负责人:TSUJI Yoshiro
-
依托单位: